ASH 2018 Prof. dr. Peter Hoogebrugge

Prof. dr. Peter Hoogerbrugge, kinderarts-oncoloog, Prinses Maxima Centrum, Utrecht 

 

Updated Analysis of the Efficacy and Safety of Tisagenlecleucel in Pediatric and Young Adult Patients with Relapsed/Refractory (r/r) Acute Lymphoblastic Leukemia

 

https://ash.confex.com/ash/2018/webprogram/Paper112599.html

 

0119HEM1092342
×

Ask Speakers

×

Medical Information Request